Raymond Lai

First Affiliated Hospital of Xi'an Jiaotong University — China

Medicine · Health Sciences

63h-index14.2kcitations338works5.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(125), Cytokine Signaling Pathways and Interactions(50), Viral-associated cancers and disorders(37), Chronic Lymphocytic Leukemia Research(33), Ubiquitin and proteasome pathways(26)

Publications337 total

Eicosapentaenoic acid attenuates hyperoxia-induced lung injury via p38 MAPK/NF-κB-mediated regulation of glycolytic reprogramming
International Immunopharmacology·2025
CD147 inhibition reduced fibronectin expression in TGF-β1-induced keloid fibroblasts by targeting Smad2 signaling pathway
Burns·2025· 5 citedOpen Access
The liquid lectin array detects compositional glycocalyx differences using multivalent DNA-encoded lectins on phage
Cell chemical biology·2024· 12 cited
ULK2 Is a Key Pro-Autophagy Protein That Contributes to the High Chemoresistance and Disease Relapse in FLT3-Mutated Acute Myeloid Leukemia
International Journal of Molecular Sciences·2024· 5 citedOpen Access
An In Vitro Model for Acute Myeloid Leukemia Relapse Using the SORE6 Reporter
International Journal of Molecular Sciences·2023· 4 citedOpen Access
Multivalent DNA-encoded lectins on phage enable detecting compositional glycocalyx differences
2023Open Access
Nuclear NPM-ALK Protects Myc from Proteasomal Degradation and Contributes to Its High Expression in Cancer Stem-Like Cells in ALK-Positive Anaplastic Large Cell Lymphoma
International Journal of Molecular Sciences·2023Open Access
Data from The Opposing Function of STAT3 as an Oncoprotein and Tumor Suppressor Is Dictated by the Expression Status of STAT3β in Esophageal Squamous Cell Carcinoma
2023Open Access
Supplementary Table S1-2 from The Opposing Function of STAT3 as an Oncoprotein and Tumor Suppressor Is Dictated by the Expression Status of STAT3β in Esophageal Squamous Cell Carcinoma
2023Open Access
Supplementary Materials and Methods from The Opposing Function of STAT3 as an Oncoprotein and Tumor Suppressor Is Dictated by the Expression Status of STAT3β in Esophageal Squamous Cell Carcinoma
2023Open Access
Supplementary Table S1-2 from The Opposing Function of STAT3 as an Oncoprotein and Tumor Suppressor Is Dictated by the Expression Status of STAT3β in Esophageal Squamous Cell Carcinoma
2023Open Access
Supplementary Figure S1-5 from The Opposing Function of STAT3 as an Oncoprotein and Tumor Suppressor Is Dictated by the Expression Status of STAT3β in Esophageal Squamous Cell Carcinoma
2023Open Access
Supplementary Materials and Methods from The Opposing Function of STAT3 as an Oncoprotein and Tumor Suppressor Is Dictated by the Expression Status of STAT3β in Esophageal Squamous Cell Carcinoma
2023Open Access
Supplementary Figure S1-5 from The Opposing Function of STAT3 as an Oncoprotein and Tumor Suppressor Is Dictated by the Expression Status of STAT3β in Esophageal Squamous Cell Carcinoma
2023Open Access
Data from The Opposing Function of STAT3 as an Oncoprotein and Tumor Suppressor Is Dictated by the Expression Status of STAT3β in Esophageal Squamous Cell Carcinoma
2023Open Access
Data from β<sub>1</sub>-Integrin Circumvents the Antiproliferative Effects of Trastuzumab in Human Epidermal Growth Factor Receptor-2–Positive Breast Cancer
2023Open Access
Data from β<sub>1</sub>-Integrin Circumvents the Antiproliferative Effects of Trastuzumab in Human Epidermal Growth Factor Receptor-2–Positive Breast Cancer
2023Open Access
Supplementary Figures 1-7, Tables 1-2 from Genetic Screening for Synthetic Lethal Partners of Polynucleotide Kinase/Phosphatase: Potential for Targeting SHP-1–Depleted Cancers
2023Open Access
Data from Genetic Screening for Synthetic Lethal Partners of Polynucleotide Kinase/Phosphatase: Potential for Targeting SHP-1–Depleted Cancers
2023Open Access
Supplementary Table 2 from β<sub>1</sub>-Integrin Circumvents the Antiproliferative Effects of Trastuzumab in Human Epidermal Growth Factor Receptor-2–Positive Breast Cancer
2023Open Access
page 1 of 17Next →

Frequent Co-authors

Hesham M. Amin(15), L. Jeffrey Medeiros(15), George Z. Rassidakis(8), John R. Mackey(6), Timothy J. McDonnell(6), Vasiliki Leventaki(5), Lynne V. Abruzzo(5), Carol E. Cass(4), Yupo Ma(4), Afsaneh Lavasanifar(4), Quan Lin(4), Dan Jones(4), Charles Dumontet(3), P. Sève(3), Ommoleila Molavi(3), Zengshuan Ma(3), Eric D. Hsi(3), Tony Reiman(3), Seán O’Connor(3), Dan Jones(3)